Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management

Immune checkpoint inhibitors are now approved for more than 50 indications, and increasing numbers of patients with advanced cancer are receiving immunotherapy. Immune-related adverse events that result from checkpoint inhibitors can affect any organ system. The most common kidney side effect is acu...

Descripción completa

Detalles Bibliográficos
Autores principales: Seethapathy, Harish, Herrmann, Sandra M., Sise, Meghan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664750/
https://www.ncbi.nlm.nih.gov/pubmed/34939017
http://dx.doi.org/10.1016/j.xkme.2021.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664750/
https://www.ncbi.nlm.nih.gov/pubmed/34939017
http://dx.doi.org/10.1016/j.xkme.2021.08.008

Ejemplares similares